Clinical trial
A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)
NCT01572948
Study timeline
Study start (unknown)2012-06-01Date precision: month
Registry last updated2015-10-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
COPDunresolved
Interventions
roflumilastDRUG · verified · RxNorm: roflumilast
placeboDRUG
Sponsors & collaborators
University of Alabama at Birminghamlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01572948 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.